Medical Care

Global Pneumonia Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Pneumonia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumonia.
The Pneumonia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumonia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumonia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GlaxoSmithKline(GSK)
Merck
Novartis
Sanofi
Eli Lilly
Segment by Type
Drugs
Vaccines
Oxygen Therapy
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pneumonia company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumonia Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Vaccines
1.2.4 Oxygen Therapy
1.3 Market by Application
1.3.1 Global Pneumonia Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pneumonia Market Perspective (2020-2031)
2.2 Global Pneumonia Growth Trends by Region
2.2.1 Global Pneumonia Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pneumonia Historic Market Size by Region (2020-2025)
2.2.3 Pneumonia Forecasted Market Size by Region (2026-2031)
2.3 Pneumonia Market Dynamics
2.3.1 Pneumonia Industry Trends
2.3.2 Pneumonia Market Drivers
2.3.3 Pneumonia Market Challenges
2.3.4 Pneumonia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Players by Revenue
3.1.1 Global Top Pneumonia Players by Revenue (2020-2025)
3.1.2 Global Pneumonia Revenue Market Share by Players (2020-2025)
3.2 Global Pneumonia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pneumonia Revenue
3.4 Global Pneumonia Market Concentration Ratio
3.4.1 Global Pneumonia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Revenue in 2024
3.5 Global Key Players of Pneumonia Head office and Area Served
3.6 Global Key Players of Pneumonia, Product and Application
3.7 Global Key Players of Pneumonia, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pneumonia Breakdown Data by Type
4.1 Global Pneumonia Historic Market Size by Type (2020-2025)
4.2 Global Pneumonia Forecasted Market Size by Type (2026-2031)
5 Pneumonia Breakdown Data by Application
5.1 Global Pneumonia Historic Market Size by Application (2020-2025)
5.2 Global Pneumonia Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pneumonia Market Size (2020-2031)
6.2 North America Pneumonia Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pneumonia Market Size by Country (2020-2025)
6.4 North America Pneumonia Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pneumonia Market Size (2020-2031)
7.2 Europe Pneumonia Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pneumonia Market Size by Country (2020-2025)
7.4 Europe Pneumonia Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pneumonia Market Size (2020-2031)
8.2 Asia-Pacific Pneumonia Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pneumonia Market Size by Region (2020-2025)
8.4 Asia-Pacific Pneumonia Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pneumonia Market Size (2020-2031)
9.2 Latin America Pneumonia Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pneumonia Market Size by Country (2020-2025)
9.4 Latin America Pneumonia Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pneumonia Market Size (2020-2031)
10.2 Middle East & Africa Pneumonia Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pneumonia Market Size by Country (2020-2025)
10.4 Middle East & Africa Pneumonia Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pneumonia Introduction
11.1.4 Pfizer Revenue in Pneumonia Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline(GSK)
11.2.1 GlaxoSmithKline(GSK) Company Details
11.2.2 GlaxoSmithKline(GSK) Business Overview
11.2.3 GlaxoSmithKline(GSK) Pneumonia Introduction
11.2.4 GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2020-2025)
11.2.5 GlaxoSmithKline(GSK) Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Pneumonia Introduction
11.3.4 Merck Revenue in Pneumonia Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Pneumonia Introduction
11.4.4 Novartis Revenue in Pneumonia Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Pneumonia Introduction
11.5.4 Sanofi Revenue in Pneumonia Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Pneumonia Introduction
11.6.4 Eli Lilly Revenue in Pneumonia Business (2020-2025)
11.6.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pneumonia Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drugs
Table 3. Key Players of Vaccines
Table 4. Key Players of Oxygen Therapy
Table 5. Global Pneumonia Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Pneumonia Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pneumonia Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Pneumonia Market Share by Region (2020-2025)
Table 9. Global Pneumonia Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Pneumonia Market Share by Region (2026-2031)
Table 11. Pneumonia Market Trends
Table 12. Pneumonia Market Drivers
Table 13. Pneumonia Market Challenges
Table 14. Pneumonia Market Restraints
Table 15. Global Pneumonia Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Pneumonia Market Share by Players (2020-2025)
Table 17. Global Top Pneumonia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia as of 2024)
Table 18. Ranking of Global Top Pneumonia Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Pneumonia Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Pneumonia, Headquarters and Area Served
Table 21. Global Key Players of Pneumonia, Product and Application
Table 22. Global Key Players of Pneumonia, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pneumonia Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Pneumonia Revenue Market Share by Type (2020-2025)
Table 26. Global Pneumonia Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Pneumonia Revenue Market Share by Type (2026-2031)
Table 28. Global Pneumonia Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Pneumonia Revenue Market Share by Application (2020-2025)
Table 30. Global Pneumonia Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Pneumonia Revenue Market Share by Application (2026-2031)
Table 32. North America Pneumonia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Pneumonia Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Pneumonia Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Pneumonia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Pneumonia Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Pneumonia Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Pneumonia Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Pneumonia Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Pneumonia Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Pneumonia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Pneumonia Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Pneumonia Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Pneumonia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Pneumonia Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Pneumonia Market Size by Country (2026-2031) & (US$ Million)
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Pneumonia Product
Table 50. Pfizer Revenue in Pneumonia Business (2020-2025) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. GlaxoSmithKline(GSK) Company Details
Table 53. GlaxoSmithKline(GSK) Business Overview
Table 54. GlaxoSmithKline(GSK) Pneumonia Product
Table 55. GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2020-2025) & (US$ Million)
Table 56. GlaxoSmithKline(GSK) Recent Development
Table 57. Merck Company Details
Table 58. Merck Business Overview
Table 59. Merck Pneumonia Product
Table 60. Merck Revenue in Pneumonia Business (2020-2025) & (US$ Million)
Table 61. Merck Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Pneumonia Product
Table 65. Novartis Revenue in Pneumonia Business (2020-2025) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Pneumonia Product
Table 70. Sanofi Revenue in Pneumonia Business (2020-2025) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Pneumonia Product
Table 75. Eli Lilly Revenue in Pneumonia Business (2020-2025) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report


List of Figures
Figure 1. Pneumonia Picture
Figure 2. Global Pneumonia Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pneumonia Market Share by Type: 2024 VS 2031
Figure 4. Drugs Features
Figure 5. Vaccines Features
Figure 6. Oxygen Therapy Features
Figure 7. Global Pneumonia Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Pneumonia Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Pneumonia Report Years Considered
Figure 13. Global Pneumonia Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Pneumonia Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Pneumonia Market Share by Region: 2024 VS 2031
Figure 16. Global Pneumonia Market Share by Players in 2024
Figure 17. Global Top Pneumonia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Pneumonia Revenue in 2024
Figure 19. North America Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Pneumonia Market Share by Country (2020-2031)
Figure 21. United States Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Pneumonia Market Share by Country (2020-2031)
Figure 25. Germany Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Pneumonia Market Share by Region (2020-2031)
Figure 33. China Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Pneumonia Market Share by Country (2020-2031)
Figure 41. Mexico Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Pneumonia Market Share by Country (2020-2031)
Figure 45. Turkey Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Pneumonia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Pneumonia Business (2020-2025)
Figure 49. GlaxoSmithKline(GSK) Revenue Growth Rate in Pneumonia Business (2020-2025)
Figure 50. Merck Revenue Growth Rate in Pneumonia Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Pneumonia Business (2020-2025)
Figure 52. Sanofi Revenue Growth Rate in Pneumonia Business (2020-2025)
Figure 53. Eli Lilly Revenue Growth Rate in Pneumonia Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies